Christopher Bishop

7PUBLICATIONS
8CO-AUTHORS
Neurology and neuromuscular diseasesToxicology (incl. clinical toxicology)PharmacogenomicsHaematological tumoursClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2026
Preservation of Extracellular and Tissue Dopamine During Tyrosine Hydroxylase Loss in Rat 6-OHDA Parkinson's Model: Selective Compensation Restricted to Substantia Nigra.

|Mar 29, 2023
Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia.

Carla Budrow, Kayla Elder, Michael Coyle

|Apr 03, 2021
Dopamine D3 Receptor Plasticity in Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Kathryn Lanza, Christopher Bishop

|Dec 18, 2019
Neuroinflammation: Fanning the fire of l-dopa-induced dyskinesia.

Christopher Bishop

|Jan 07, 2018
Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.

Kathryn Lanza, Christopher Bishop

|Jul 02, 2017
D-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats.

David Lindenbach, Banibrata Das, Melissa M Conti

Pageof 2

Frequent Collaborators

1 joint publications

David Lindenbach

1 joint publications

Kathryn Lanza

1 joint publications

Michael Coyle

1 joint publications

Ashley Centner